Press releases and news

Senzime's US subsidiary, Senzime Inc, has gradually expanded during the year and has recently completed its first stage of commercial development. The direct sales team as well as the companies two distributors are currently running evaluations across...
2020-12-23 16:15 Senzime granted US Patent for OnZurf Probe Regulatory
The OnZurf Probe was acquired by Senzime in 2016 and is based on an innovation by Dr. Pernilla Abrahamsson and clinical research at Umeå University. The development, including CE approval of OnZurf, was completed by Senzime in 2017. The probe is...
This is the sixth larger order placed by Senzimes distributor in South Korea since their market launch in August 2019. There are more than 3,000 hospitals in South Korea and more than 700 000 operations are performed annually where anesthesia and muscle...
The Directed Issue The board of directors of Senzime has, in accordance with the issue authorization granted by the annual general meeting on 14 May 2020 and as indicated in the press release of the Company earlier today, resolved on a directed issue...
The Directed Issue The Directed Issue is intended to be carried out with deviation from the shareholders’ preferential rights in accordance with the issue authorization granted by the Annual General Meeting on 14 May 2020. The subscription price...
2020-11-26 12:23 UK sales success story
Established in 2003, Healthcare 21 is now one of Europe's largest privately owned MedTech companies. Having recently embarked on a programme of acquisition, their 3-year goal is to build a pan-European sales, marketing, service and distribution company...
All 600,000 options in the program have been exercised for subscription of shares and the Company has thus issued 600,000 new shares to the option holders at a price of SEK 8.80 per new share. The Company has thereby received approximately SEK 5.3 million...
This is the fifth larger order placed by Senzimes distributor in South Korea since their market launch in August 2019. There are more than 3,000 hospitals in South Korea and more than 700 000 operations are performed annually where anesthesia and muscle...
The Task Force has been set-up to provide the rationale and scientific basis for the use of neuromuscular blocking agents in current anaesthesia practice and will also offer a set of recommendations for neuromuscular blockade management. Guidelines-in-development...
2020-11-06 08:45 Senzime’s Interim report January – September 2020 Regulatory Interim
Financial information for the third quarter 2020 Financial information for January-September 2020 The increased access to hospitals towards the end of the quarter meant that September’s sales were the best ever in Senzime’s history. In the...